Advanced Imaging Cardiologist | Program Director, Advanced CV Imaging Fellowship | Medical Director, Cardiac MRI @CUAnschutz🇲🇽 🇺🇸
Denver, CO
Joined April 2019
- Tweets1K
- Following705
- Followers1.6K
- Likes4.7K
Raymundo A. Quintana, MD retweeted
We are just getting started
Raymundo A. Quintana, MD retweeted
Original Article: Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults (STAREE trial) nej.md/4ghHPSC
Editorial: Statins in Older Adults — Evidence at Last nej.md/4ynHp57
#Cardiology #ESCCongress
ALT This image is two panels showing major cardiovascular events and disability-free survival according to trial group. Panel A shows the cumulative incidence of major cardiovascular events. The graphs on the left show the cumulative incidence of primary end-point events (death from cardiovascular causes, nonfatal myocardial infarction or stroke, or coronary revascularization, whichever occurred first), and those on the right the cumulative incidence of composite secondary end-point events (death from cardiovascular causes, myocardial infarction, or stroke, whichever occurred first). Panel B shows the cumulative incidence of death from any cause, dementia, or persistent physical disability, whichever occurred first, as a measure of disability-free survival. Insets show the same data on an expanded y axis.
Raymundo A. Quintana, MD retweeted
We’re sharing a solution to the Navier-Stokes Millennium Prize Problem, one of the deepest problems at the frontier of mathematics.
The proof was produced by a group of agents, using an OpenAI next-generation model significantly more capable than GPT-6 Astra.
The problem concerns whether the description of smooth three-dimensional fluid motion modeled by the Navier-Stokes equations can break down. It has remained unresolved for roughly 90 years.
Raymundo A. Quintana, MD retweeted
Novartis announces Lp(a)HORIZON Phase III topline results
“did not meet its primary endpoint”
There will be a lot to unpack here globenewswire.com/news-relea…
Raymundo A. Quintana, MD retweeted
I have to say, this is pretty wild. The CEO and financial stakeholders of a company that stands to benefit from replacing physicians with AI publish a Perspective in @JAMA_current arguing for that technology, then take to social media to promote it and tag @CMSGov?
Game mostly over for human doctors vs. AI? @ZekeEmanuel @AbeBakerButler @nealkhosla and I just published in @JAMA_current: AI-alone may provide better patient care than physicians or physician-controlled hybrids at 5 fundamental cognitive medical tasks is unsettling but seems probable. Even when AI alone is superior, significant barriers to implementation remain. Nonetheless, superior autonomous AI will likely be ready to be deployed for real-world cognitive medical tasks in some, maybe many, workflows by 2030. Consequently, physicians, policymakers, and others need to urgently devise approaches to workflow, liability, regulation, reimbursement, and medical education.
@DrOz @1klomp time for @CMSGov @CMSinnovates to take note: Will Autonomous AI Exceed AI-Aided Physicians as the Best Medical Care?
jamanetwork.com/journals/jam…
Love this! We should consider getting of the term LV Non-compaction.
Is Left ventricular hypertrabeculation a distinct entity that requires specific therapeutic management? 🤔
Check our latest study published @CircAHA . 1160 DCM with CMR & 🧬 from 22 🇪🇸/🇳🇱🏥
Amazing work by @NereMA and Noemí Ramos. Congrats! 🎉🎊
See🧵👇🏻
ahajournals.org/doi/10.1161/…
Raymundo A. Quintana, MD retweeted
Is Left ventricular hypertrabeculation a distinct entity that requires specific therapeutic management? 🤔
Check our latest study published @CircAHA . 1160 DCM with CMR & 🧬 from 22 🇪🇸/🇳🇱🏥
Amazing work by @NereMA and Noemí Ramos. Congrats! 🎉🎊
See🧵👇🏻
ahajournals.org/doi/10.1161/…
🔥 Is left ventricular hypertrabeculation really a risk marker in dilated cardiomyopathy - or have we been overdiagnosing and overtreating an imaging finding?
🚨 We are thrilled to share our study, now published in @CircAHA !
Raymundo A. Quintana, MD retweeted
Caristo’s CaRi-Heart® debuts in the U.S.! A landmark moment for #cardiovascularcare — and a major win for science, clinicians, and patients! 🎉CaRi-Heart has received U.S. FDA De Novo authorization, becoming the first and only technology authorized in the U.S. to detect and quantify coronary inflammation from routine coronary CT angiography (CCTA).
This milestone reflects more than a decade of pioneering science, relentless work, and shared belief in a future where cardiovascular disease can be detected earlier, treated more personally, and patients can live longer, healthier lives.
Read the full announcement: caristo.com/caristo-diagnost… #CaRiHeart #CaristoDiagnostics #CoronaryInflammation #FAIScore #PreventiveCardiology #CardiacCT #AIinHealthcare #MedTech #FDA #Cardiology
ALT CaRi-Heart Technology Authorized by U.S. FDA
This is crazy! The last thing we need is people betting on the outcomes of clinical trials.
Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvals trib.al/PNFFula
Raymundo A. Quintana, MD retweeted
JUST IN: Senegal’s team doctor at the 2026 World Cup revealed to be a gynecologist, without the appropriate sports-medicine credentials.
New proposal for diagnosing acromegaly in 2026: forget asking patients for an old driver’s license. Just pull up their Facebook profile and scroll back to photos from 10 years ago. @TheAACE @TheEndoSociety
Nobody beats @miseleccionmx at the Estadio Azteca—not even @England! 🇲🇽🔥
Unexpected AY 2027–2028 fellowship opening: Advanced Cardiovascular Imaging Program at the University of Colorado. Highlights include ~1,500 CMRs/year, ~5,500 cardiac CTs/year, dedicated cardiac technologists, and a collaborative environment between cardiology and chest rads.
Interested applicants: please contact me directly at [email protected]. medschool.cuanschutz.edu/car…
Well, I like the references from reputable journals that I get with @openevidence and the CME @UpToDate gives.
For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @openevidence and @UpToDate as assessed by 12 US clinicians, randomized and blinded to which model and extensive testing/benchmarks. This was not anticipated. @NatureMedicine
nature.com/articles/s41591-0…
Raymundo A. Quintana, MD retweeted
@ShivdevRao: Clinician attention pulled away from patients by “competing priorities” and “boxes to check.”
Four in 10 clinicians burning out. A third thinking about leaving the profession.
Clinicians are "stitching together workflows" that involve providers, payers, and life sciences.